C07D 291/04
Five-membered rings
C07D291/04 (Five-membered rings) appears on 46 US grants and 45 published applications in this corpus.
Search patents in C07D- Granted patents
- 46
- Published applications
- 45
- Assignees
- 35
- Inventors
- 149
- Latest grant
- 10 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 5 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 2 |
| 2003 | 1 | 3 |
| 2004 | 0 | 3 |
| 2005 | 1 | 2 |
| 2006 | 2 | 5 |
| 2007 | 2 | 4 |
| 2008 | 1 | 1 |
| 2009 | 0 | 1 |
| 2010 | 4 | 2 |
| 2011 | 0 | 4 |
| 2012 | 1 | 1 |
| 2013 | 1 | 2 |
| 2014 | 1 | 3 |
| 2015 | 2 | 2 |
| 2016 | 2 | 0 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 1 |
| 2022 | 1 | 2 |
| 2023 | 2 | 1 |
| 2024 | 0 | 1 |
| 2025 | 1 | 2 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- FABP4/5 inhibitors, methods of use and methods of making10 Mar 2026US 12,570,603 B2Celloram Inc.
- O-substituted serine derivative production method27 May 2025US 12,312,297 B2Chugai Seiyaku Kabushiki Kaisha
- Modulators of eukaryotic initiation factor 2B, compositions and methods26 Dec 2023US 11,851,440 B2Denali Therapeutics Inc.
- Additive for non-aqueous electrolyte solution, electrolyte solution for non-aqueous electrolyte solution battery, and non-aqueous electrolyte solution battery3 Jan 2023US 11,545,697 B2Central Glass Company, Limited
- Modulators of eukaryotic initiation factor 2B, compositions and methods1 Feb 2022US 11,236,100 B2Denali Therapeutics Inc.
- Fabp4/5 inhibitors, methods of use and methods of making14 May 2026US 2026/0132106 A1Celloram Inc.
- Modulators of eukaryotic initiation factor 2b, compositions and methods25 Dec 2025US 2025/0388595 A1Denali Therapeutics Inc.
- O-substituted serine derivative production method21 Aug 2025US 2025/0263365 A1Chugai Seiyaku Kabushiki Kaisha
- Novel methods for synthesizing enantiopure (s)-methadone, (r)-methadone, racemic (r,s)-methadone and related analogue substances4 Jul 2024US 2024/0217919 A1
- Fabp4/5 inhibitors, methods of use and methods of making18 May 2023US 2023/0150931 A1Novius Therapeutics, LLC
Most cited
By later US patents
- Novel naphthalenylalkyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents41US 4,897,405 AAmerican Home Products Corporation · 1990
- 1-heterocycle substituted diarylamines38US 6,545,030 B1Warner-Lambert Company · 2003
- Novel benzyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents34US 4,895,862 AAmerican Home Products Corporation · 1990
- Oxathi(SIV)azol-5-one compounds23US 5,087,631 AGlaxo Inc. · 1992
- 3-Aryl-4-isoxazolecarboxylic acids as plant growth regulants14US 4,144,047 AMonsanto Company · 1979